Helico
Helico is a biotechnology company that leverages plant-based production platforms to manufacture medicinal compounds and life-saving drugs. Utilizing innovative research in computational biology, plant physiology, and synthetic biology, Helico has developed a proprietary platform called BioVerge, which includes SeqOptima (sequence optimization) and Verdantix (plant models for protein production). This platform enables the production of biologics and biosimilars at lower costs and in a fraction of the time compared to traditional host systems. Helico's approach focuses on making medicines more accessible globally, with a commitment to environmental sustainability through carbon-neutral manufacturing processes. They offer services in molecular production design, computational biotechnology, plant physiology improvements, and contract manufacturing of biologics, and are developing an internal pipeline including insulin, oncology antibodies, and vaccines.
Helico
Helico is a biotechnology company that leverages plant-based production platforms to manufacture medicinal compounds and life-saving drugs. Utilizing innovative research in computational biology, plant physiology, and synthetic biology, Helico has developed a proprietary platform called BioVerge, which includes SeqOptima (sequence optimization) and Verdantix (plant models for protein production). This platform enables the production of biologics and biosimilars at lower costs and in a fraction of the time compared to traditional host systems. Helico's approach focuses on making medicines more accessible globally, with a commitment to environmental sustainability through carbon-neutral manufacturing processes. They offer services in molecular production design, computational biotechnology, plant physiology improvements, and contract manufacturing of biologics, and are developing an internal pipeline including insulin, oncology antibodies, and vaccines.